Vera H. Rigolin, MD

5.0 
979 ratings  Read Reviews
Northwestern Medicine logoNorthwestern Medical Group

Primary Specialty

Cardiology

Is your insurance accepted? Select plan

Schedule Appointment
Practice Website

Practice Focus Areas

Education

Medical Education:
MD, Northwestern University Feinberg School of Medicine - 1988
Residency:
McGaw Medical Center of Northwestern University - 1991
Fellowships:
Duke University Hospital - 1995

Languages Spoken

  • Portuguese

Board Certifications

  • American Board of Internal Medicine - Cardiovascular Disease (Certified)

Faculty Profile

Professor, Feinberg School of Medicine

View Faculty Profile

Practice Groups and Affiliations

Medical Group:
Northwestern Medical Group
Alignment Category:
Northwestern Medicine Physician Network
On Medical Staff At:
Northwestern Memorial Hospital
Palos Hospital

Ratings and Reviews

At Northwestern Medicine, our patient’s feedback is important to us. While different care providers have their own unique strengths, we strive to be as transparent as possible with our quality of care.

Read Ratings FAQs

Overall Rating

5.0
5.0 

979 Ratings

Reviews from Patients

98 Reviews

Reviews from Patients

98 Reviews

April 24, 2024

5.0

I feel fortunate to have Dr Rigolin as my cardiologist. Dr Rigolin is outstanding and goes above and beyond through her kindness and attention to detail.

Was this helpful? Yes (2) No (1)

April 24, 2024

5.0

Dr Rigolin is a standout physician. She knows the latest research, is an excellent listener and explains everything you need to know clearly and thoroughly. She is a great communicator with great "bedside" manner. She shares my hopes to use all the tools available for a long, healthy life. She has great nurses, too, that are fast in replying to any questions. AND she is punctual with her appointments!

Was this helpful? Yes (1) No (0)

April 24, 2024

5.0

Dr. Vera Rigolin was highly recommended to me by several of my friends and I agree with their assessment. Even though I did not come to my appointment with my questions written down (I have lately been very busy), Dr. Rigolin gave me detailed explanations of the issues I raised and did not make me feel as if my lack of organization was a problem for her or that I was questioning her professional judgement. I am grateful to have found a cardiologist who can help me understand how to navigate a new and potentially stress experience.

Was this helpful? Yes (0) No (0)

April 22, 2024

5.0

She was very thorough and explain my condition thoroughly to me.

Was this helpful? Yes (0) No (0)

April 17, 2024

5.0

Her knowledge, kindness and ease to talk with - most of all her care.

Was this helpful? Yes (2) No (0)

Disclosures

Industry Relationships

Ownership or Investment Interests

Faculty member had an ownership or investment interest in the following companies

  • Amgen, Inc.
  • Edwards Lifesciences, LLC
  • Regeneron Pharmaceuticals, Inc.

External Professional Relationships

Pharmaceutical, device, and biotechnology companies frequently collaborate with basic scientists and physicians within an academic medical center to help advance science and improve patient care. These relationships are important in achieving scientific breakthroughs and in establishing the effectiveness and safety of promising new therapies. In order to assure objectivity in clinical research and patient care, the Northwestern University Feinberg School of Medicine (Feinberg), Northwestern Memorial HealthCare, Children's Hospital of Chicago Medical Center, and the Shirley Ryan AbilityLab have adopted integrity policies that require research and clinical faculty (in full-time, part-time, and unpaid/voluntary categories) to report compensated and uncompensated external industry relationships. Patients are encouraged to discuss these disclosures with their physician as well as to inquire as to how these relationships are overseen by Feinberg. To learn more about our Disclosure and Professional Integrity Policy, and the conflict of interest policies of our joint affiliate survey partners, please go to our Office for Regulatory Affairs Policies page.